A case study of lung cancer patients in term of various risk factors in context of Bangladesh

A case study of lung cancer patients in term of various risk factors in context of Bangladesh

This thesis is submitted in partial fulfilment of the requirements for the degree of Bachelor of Science in Microbiology, 2018.

Détails bibliographiques
Auteur principal:	Shabnam, Musharrat
Autres auteurs:	Islam, Mohammad Rafiqul
Format:	Thèse
Langue:	English
Publié:	BRAC University 2018
Sujets:	Lung cancer Chronic obstructive pulmonary disease Ahsania Mission Cancer Hospital Lungs - Cancer HEALTH & FITNESS - Diseases - Cancer MEDICAL - Oncology.
Accès en ligne:	http://hdl.handle.net/10361/10726

Documents similaires

Molecules associated with the development of lung cancer
par: Rahman, Adree, et autres
Publié: (2023)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
par: Pial, Sazia Afrin
Publié: (2018)

Protein biomarkers for Lung Cancer: a bioinformatic approach
par: Jeba, Joynob
Publié: (2017)

A review on targeted therapies for lung cancer
par: Ashraf, Anushey
Publié: (2023)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
par: Bristy, Israt Zerin
Publié: (2021)

Potential of liposomes for the treatment of lung cancer- a review
par: Mim, Shanzida
Publié: (2023)

A review on recent advances in drugs for lung cancer treatment
par: Noor, Fouzia
Publié: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
par: Rahman, Tasnim
Publié: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
par: Razna, Amrin Islam
Publié: (2019)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
par: Tania, Umme
Publié: (2023)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
par: Hoque, Ismoth Ara
Publié: (2024)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
par: Paul, Pulock
Publié: (2024)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
par: Zangmo, Thinley
Publié: (2024)

Immunotherapy in the Management of Lung Cancer
par: Tasnim, Humayra
Publié: (2022)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Flora, Sanzida Alam
Publié: (2024)

Lung cancer detection and classification using machine learning
par: Arefin, Mahbubul, et autres
Publié: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
par: Das, Reshita
Publié: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
par: Roy, Hredita
Publié: (2018)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
par: F. S. Amaral, André, et autres
Publié: (2017)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
par: Rahman, Sanjida
Publié: (2024)

Prevalence and risk factors of chronic obstructive pulmonary disease in Bangladesh: A systematic review
par: Sutradhar, Ipsita, et autres
Publié: (2022)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
par: Hossain, Safa Binte
Publié: (2019)

Statistics and informatics in molecular cancer research

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
par: Nawar, Anika
Publié: (2019)

Cancer risk factors: a critical review
par: Tabassum, Tahsina
Publié: (2017)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
par: Mukti, Roushney Fatima, et autres
Publié: (2016)

The current cancer situation in metropolitan Dhaka
par: Morshid, Golam
Publié: (2023)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
par: Rithin, Rafia Islam
Publié: (2022)

A brief survey on the effect of smoke of different sources on COPD patients
par: Nawal, Nusrat
Publié: (2021)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
par: Nandy, Aditi
Publié: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
par: Abir, Shifaty Nur
Publié: (2024)

Targeting BRAFV600E in the treatment of CRC
par: Roja, Mashwiyat Samrin
Publié: (2024)

Application of NSAIDs in the treatment of pulmonary diseases- a comparative study of the therapeutic & the adverse impacts
par: Rahman, Farhana
Publié: (2021)

Role of statins as antagonists of SPARC in gastric cancer
par: Shahmat, Rad
Publié: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Karim, Samia Binte
Publié: (2024)

Epigenetic therapy in cancer
par: Abid, Md. Shadman Ridwan
Publié: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
par: Khondokar, Faiza
Publié: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
par: Jahan, Nusrat
Publié: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
par: Raihan, Dilraj
Publié: (2024)

Biosimilar in lymphoma treatment
par: Tanisha, Mehrin Haque
Publié: (2021)